In the original publication [1], there was a mistake in Figure 3c as published. In referring to the description for Hepcidin expression (as Figure 3c), the order of priority for the GDM group and the non-GDM group was reversed in the original version and in the revised version. The authors wish to apply for a correction. Figure 3c should be replaced with the following figure:
Figure 3.
Immunohistochemistry images demonstrated that the lower expression of Hep on the membrane of the basal cells (arrow) in the GDM group (a) compared to that in the non-GDM group (b) (×200 magnification). A lower immunohistochemistry score was found in the GDM group compared with the non-GDM group (c) p = 0.044.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Yang, A.; Zhao, J.; Lu, M.; Gu, Y.; Zhu, Y.; Chen, D.; Fu, J. Expression of Hepcidin and Ferroportin in the Placenta, and Ferritin and Transferrin Receptor 1 Levels in Maternal and Umbilical Cord Blood in Pregnant Women with and without Gestational Diabetes. Int. J. Environ. Res. Public Health 2016, 13, 766. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).